Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller.
The Sacklers will no longer have liability protection from future lawsuits. The company and the once-prominent family behind the drug OxyContin agreed Thursday to increase their financial ...
NEW YORK, Jan 23 (Reuters) - Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin ...
Jan. 23 (UPI) --The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states. New York Attorney ...
Purdue Pharma and the members of the Sackler family who own the company agreed in principle to pay a $7.4 billion settlement to resolve thousands of lawsuits over their alleged role in the opioid ...
The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024.
The settlement will conclude the most expensive corporate bankruptcy tied to the opioid epidemic, which has claimed at least 106,000 lives. 'This story is about a family of cruel billionaires who ...
Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid ...
Purdue Pharma’s owners from the Sackler family have struck a new $6.5 billion settlement of mass litigation alleging they fueled addiction, reopening a path to end the longest and costliest ...
Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication Oxycontin caused a widespread opioid ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...